Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10,950.00
Bid: 10,800.00
Ask: 11,100.00
Change: 50.00 (0.46%)
Spread: 300.00 (2.778%)
Open: 10,900.00
High: 10,950.00
Low: 10,900.00
Prev. Close: 10,900.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Heath Scientific Company Limited

29 May 2020 07:00

RNS Number : 2919O
Judges Scientific PLC
29 May 2020
 

Press Release

29 May 2020

Judges Scientific plc

("Judges Scientific", "Judges", the "Company" or the "Group")

Acquisition of Heath Scientific Company Limited

Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, announces that it has acquired today the entire issued share capital of Heath Scientific Company Limited ("Heath" or the "Acquisition"), a world leading maker of calorimetry instruments. The Board expects the Acquisition to be immediately earnings enhancing.

The initial consideration for Heath is £5.3 million in cash. The consideration for the Acquisition has been financed from the Group's £35 million acquisition facility from Lloyds Bank Corporate Markets.

Information and rationale for the Acquisition

Heath, through its subsidiaries Thermal Hazard Technology Limited and THT Inc., specialises in the design, manufacture and sale of instruments used to measure the thermal properties of lithium batteries and other reactive materials. Its main product, the Accelerating Rate Calorimeter, is a key tool to improve and verify the safety of lithium batteries and of other chemical reactions. This is an expanding market in light of the growth in the use of lithium batteries in electronic devices and electric vehicles.

The science underlying Heath's products is similar to the scientific fundamentals of Fire Testing Technology, the Group's first acquisition in May 2005. In addition, the aim of both companies is to improve the safety of the products manufactured by their customers. The Board believes the interaction between the two companies will be constructive.

Heath, based in Bletchley, Buckinghamshire, was established in 1994 by Martyn Ottaway (the Managing Director) and Phill O'Kane (the Sales and Marketing Director); they were joined in 1996 by Stelios Mores, the R&D Director. The founders, in some cases with their families, each owned approximately one third of the shares in Heath. Following the acquisition Martyn will retire but remain on the board of Heath as a non-executive director; his son Stephen, the Business Development Director, recently joined Phill and Stelios on the board and the three will lead the company in the future.

Heath's accounts for the financial year to 30 April 2019 show revenues of £4.4 million and pre-tax profits of £0.7 million. Net tangible assets amounted to £1.9 million, including cash of £0.8 million. Heath's operating profit for the year ended 30 April 2019, adjusted to eliminate non-recurring items and to reflect Heath's ongoing cost base within Judges, would have totalled £879,000. 

Terms of the Acquisition

The purchase price of Heath consists of the following:

· The initial price, paid in cash at completion, amounting to £5.3 million;

· Potential further contingent consideration of up to a maximum £2.0 million in aggregate ("Earn-out Consideration") to be satisfied in cash.

The Earn-out Consideration will be payable if and to the extent that Heath's adjusted EBIT in the financial year to 30 April 2020 or in the 12-month period to 31 December 2020 exceeds £879,000. The Earn-out Consideration may be payable in two tranches and the maximum earn-out would be payable if, in either period, adjusted EBIT exceeds £1.22 million.

An additional payment will also be due if there is an excess cash balance over and above the ongoing requirements of the business. The Board expects any such payment to be covered by the cash inherited at the completion date. 

Alex Hambro, Chairman of Judges, said:

"Heath is a world leading business in a focused global niche, selling quality products which are indispensable to the safety of the public. This cash generative and earnings enhancing acquisition fits within the Judges disciplined acquisition strategy. We are delighted to welcome Phill, Stelios and Stephen and all their colleagues to Judges' family."

 

For further information please contact:

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Joint Broker)

 

Stephane Auton

Edward Mansfield

Sarah Mather

Tel: +44 (0) 20 7408 4090

 

 

 Liberum (Joint Broker)

Bidhi Bhoma

Euan Brown

 

Tel: +44 (0) 20 3100 2222

 

Media enquiries:

Alma PR (Financial Public Relations)

 

Rebecca Sanders-Hewett

Sam Modlin

 

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group now consists of 18 businesses acquired since it was re-admitted to AIM in 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQKZGZKLRDGGZM
Date   Source Headline
16th Apr 20247:00 amRNSDirector/PDMR Shareholding
9th Apr 20245:29 pmRNSDirector/PDMR Shareholding
2nd Apr 202410:41 amRNSTotal Voting Rights - Correction
2nd Apr 20249:03 amRNSTotal Voting Rights
25th Mar 20246:01 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSFinal Results
7th Mar 20247:00 amRNSDirector/PDMR Shareholding
4th Mar 202411:04 amRNSTotal Voting Rights
22nd Feb 20245:20 pmRNSHolding(s) in Company
6th Feb 20243:03 pmRNSDirector/PDMR Shareholding
5th Feb 20249:32 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSAcquisition of Luciol Instruments SA
24th Jan 20245:52 pmRNSGrant of Options
18th Jan 20247:00 amRNSFull Year Trading Statement and Notice of Results
8th Jan 20242:21 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:49 amRNSTotal Voting Rights
21st Dec 20234:16 pmRNSDirector/PDMR Shareholding
21st Dec 20239:13 amRNSBlock listing Interim Review
7th Dec 202311:18 amRNSDirector/PDMR Shareholding
1st Dec 202311:20 amRNSTotal Voting Rights
22nd Nov 202310:41 amRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSBoard Changes
15th Nov 202312:54 pmRNSDirector/PDMR Shareholding
9th Nov 202312:36 pmRNSDirector/PDMR Shareholding
9th Oct 202311:36 amRNSDirector/PDMR Shareholding
3rd Oct 202311:13 amRNSTotal Voting Rights
26th Sep 202310:37 amRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSInterim Results
6th Sep 20237:00 amRNSNotice of Investor Presentation
2nd Aug 20233:02 pmRNSTotal Voting Rights
26th Jul 202311:20 amRNSDirector/PDMR Shareholding
18th Jul 20237:00 amRNSHalf Year Trading Update and Notice of Results
10th Jul 20233:03 pmRNSDirector/PDMR Shareholding
3rd Jul 20233:44 pmRNSTotal Voting Rights
22nd Jun 20233:09 pmRNSBlock listing Interim Review
14th Jun 20238:44 amRNSDirector/PDMR Shareholding
6th Jun 20238:45 amRNSPayment of Earn-out and Issue of Equity
5th Jun 20234:17 pmRNSDirector/PDMR Shareholding
1st Jun 20237:00 amRNSBlocklisting Application and Total Voting Rights
22nd May 20231:45 pmRNSResult of AGM
12th May 20232:01 pmRNSPurchase of Ordinary Shares
9th May 202312:37 pmRNSDirector/PDMR Shareholding
3rd May 20237:00 amRNSNotice of AGM
2nd May 20231:00 pmRNSTotal Voting Rights
2nd May 20237:00 amRNSAcquisition of Bossa Nova Vision LLC
25th Apr 20235:55 pmRNSDirector/PDMR Shareholding
6th Apr 20232:50 pmRNSDirector/PDMR Shareholding
4th Apr 202312:21 pmRNSTotal Voting Rights
3rd Apr 20237:01 amRNSAcquisition of Henniker Scientific Limited
3rd Apr 20237:00 amRNSAppointment of Joint Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.